par Legros, Benjamin 
;Bottin, P;de Borchgrave d'Alténa, Valérie;Delcourt, C;De Tourtchaninoff, Marianne;Dubru, J M;Foulon, Martine ;Ghariani, S;Grisar, T;Hotermans, Christophe;Ossemann, M;Sadzot, B.;Tugendhaft, P;Van Bogaert, Patrick ;van Rijckevorsel, Kenou;Verheulpen, Denis
Référence Acta neurologica belgica, 103, 3, page (135-139)
Publication Publié, 2003-09
;Bottin, P;de Borchgrave d'Alténa, Valérie;Delcourt, C;De Tourtchaninoff, Marianne;Dubru, J M;Foulon, Martine ;Ghariani, S;Grisar, T;Hotermans, Christophe;Ossemann, M;Sadzot, B.;Tugendhaft, P;Van Bogaert, Patrick ;van Rijckevorsel, Kenou;Verheulpen, Denis Référence Acta neurologica belgica, 103, 3, page (135-139)
Publication Publié, 2003-09
Article révisé par les pairs
| Résumé : | Approximately 20% of people with epilepsy are of childbearing potential and about 3 to 5 births per thousand will be to women with epilepsy. Both epilepsy and antiepileptic drugs can cause specific problems in women and embryos (less than 8 weeks of gestational age) or foetuses (more than 8 weeks of gestational age). The aim of this paper is to discuss therapeutic issues for the management of women with epilepsy: initiation of antiepileptic therapy, contraception, pregnancy, breast feeding and menopause. Some fertility issues are also discussed. |
